Suggestions
David Ni
Capital Markets Partner at Sidley Austin LLP
David Ni is a Partner at Sidley Austin LLP, specializing in capital markets.12 He represents issuers, underwriters, and selling securityholders in various public and private offerings.1
Expertise and Practice Areas
David Ni's areas of focus include:
- Initial public offerings
- Follow-on offerings
- Acquisition and leveraged finance transactions
- Debt restructurings
- Liability management transactions
- PIPEs and private placements
- SPAC initial public offerings and "de-SPACings"
- At-the-market offerings
- Bank note offerings
- Medium-term notes offerings1
He counsels companies on a wide range of financial products, including debt (both investment grade and high-yield), common stock, preferred stock, depositary shares, warrants, trust preferreds, regulatory capital, Eurobonds, convertible notes, and other hybrid securities.1
Industry Experience
David works across diverse industries, including:
- Energy
- Technology
- Media and telecommunications
- Life sciences
- Financial services1
Leadership and Recognition
David serves as co-leader of Sidley Austin's Special Purpose Acquisition Companies (SPACs) group.1 He has been recognized for his expertise in the field, being named a "Rising Star" in IFLR 1000 for multiple years (2015-2022).1
Additional Responsibilities
In addition to his transactional work, David regularly advises public companies on:
- Corporate governance matters
- Ongoing reporting obligations
- Exchange listing requirements1
Background
Prior to joining Sidley Austin, David was a capital markets partner at another global law firm.1 He has also completed secondments at the equity capital markets desk of a prominent bulge bracket investment bank and the Office of the Prosecution at the International Criminal Tribunal for Rwanda.1
David's educational background includes the University of Toronto.2
Highlights
I am looking forward to attending the 2023 SPAC Conference next week and speaking on "How Accounting, Finance and Legal Experts Can Help You De-Risk Deal Executions." Join us for a panel discussion on understanding where the numbers come from – and whether they add up. I look forward to connecting with you!
Anyone know of a foundation that'll support research on novel treatments of autism, ASD, etc.?
